THE EUROPEAN COMMISSION APPROVES EXPANDED USE OF JANSSEN’S STELARA® (USTEKINUMAB) FOR THE TREATMENT OF PAEDIATRIC PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
- EMEA Innovative Medicine
- THE EUROPEAN COMMISSION APPROVES EXPANDED USE OF JANSSEN’S STELARA® (USTEKINUMAB) FOR THE TREATMENT OF PAEDIATRIC PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
THE EUROPEAN COMMISSION APPROVES EXPANDED USE OF JANSSEN’S STELARA® (USTEKINUMAB) FOR THE TREATMENT OF PAEDIATRIC PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
- X (Twitter)
Copy link